Exchange: NYSEArca·Updated 04:55 PM EDT
IYH logo

IYHiShares US Healthcare ETF

$68.50
$0.06
(0.09%)
Today
Closed $68.62
$0.12
(0.17%)
After Hours
Vol270,813.00
52W High$69.93
52W Low$53.94
News
all
press releases
Anxious About an AI Bubble? ETFs to Help Navigate the Risk
Stretched tech valuations are reviving AI bubble fears. These ETFs can help navigate the uncertainty.
Zacks
News Placeholder
More News
News Placeholder
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Sector ETF report for IYH
Zacks
News Placeholder
ETFs That May Provide Investors Protection From Market Risks
Geopolitical tensions and tech weakness are fueling volatility in U.S. markets. Explore ETFs for portfolio stability.
Zacks
News Placeholder
Too Much Tech in Your Portfolio? ETFs to Help You Diversify
The recent rotation out of AI-linked stocks highlights the risks of a narrow market rally. As concentration risk rises, defensive ETFs could help investors build more resilient portfolios.
Zacks
News Placeholder
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.
Zacks
News Placeholder
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Sector ETF report for IYH
Zacks
News Placeholder
Consumer Sentiment Weakens: ETFs That Are Worth a Look
Rising oil prices and Middle East tensions are squeezing household finances and weakening consumer sentiment, steering investors toward defensive ETFs.
Zacks
News Placeholder
Stagflation Scare? ETFs May Help Protect Your Portfolio
Are stagflation risks returning as oil-driven inflation rises amid Middle East tensions? Here's how ETFs can help defend portfolios.
Zacks
News Placeholder
Middle East Turmoil and U.S. Debt Surge: ETFs in Focus
With U.S. budget deficits and already elevated debt, the ongoing Middle East war could worsen the fiscal outlook, making defensive ETF strategies worth considering for stability.
Zacks
News Placeholder
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue
The company generated $147 million in revenue during Q4, a 67% year-on-year (YoY) increase. Earnings per share (EPS) for the quarter were $0.11.
Stocktwits
<
1
2
...
>